MedTrace Logo

The Effect on Depressive Symptoms in ECF Residents With COPD

NCT00974246 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2016-12-28

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to assess the effect of treatment with Advair Diskus on depression using the Cornell depression scale in COPD patients in the nursing home.

Conditions

Interventions

DRUG

Advair diskus

Advair diskus 50/250 1 inhalation bid for 16 weeks

Sponsors & Collaborators

  • Valley Medical Research

    lead OTHER

Principal Investigators

  • Meenakshi Patel, MD · Valley Medical Research

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
94 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00974246 on ClinicalTrials.gov